BACKGROUND AND PURPOSE: ApolipoproteinE-deficient [apoE (-/-)] mice, a model of human atherosclerosis, develop endothelial dysfunction caused by decreased levels of nitric oxide (NO). The endogenous peptide, angiotensin-(1-7) [Ang-(1-7)], acting through its specific GPCR, the Mas receptor, has endothelium-dependent vasodilator properties. Here we have investigated if chronic treatment with Ang-(1-7) improved endothelial dysfunction in apoE (-/-) mice. EXPERIMENTAL APPROACH: ApoE (-/-) mice fed on a lipid-rich Western diet were divided into three groups and treated via osmotic minipumps with either saline, Ang-(1-7) (82 µg·kg(-1) ·h(-1) ) or the same dose of Ang-(1-7) together with D-Ala-Ang-(1-7) (125 µg·kg(-1) ·h(-1) ) for 6 weeks. Renal vascular function was assessed in isolated perfused kidneys. KEY RESULTS: Ang-(1-7)-treated apoE (-/-) mice showed improved renal endothelium-dependent vasorelaxation induced by carbachol and increased renal basal cGMP production, compared with untreated apoE (-/-) mice. Tempol, a reactive oxygen species (ROS) scavenger, improved endothelium-dependent vasorelaxation in kidneys of saline-treated apoE (-/-) mice whereas no effect was observed in Ang-(1-7)-treated mice. Chronic treatment with D-Ala-Ang-(1-7), a specific Mas receptor antagonist, abolished the beneficial effects of Ang-(1-7) on endothelium-dependent vasorelaxation. Renal endothelium-independent vasorelaxation showed no differences between treated and untreated mice. ROS production and expression levels of the NAD(P)H oxidase subunits gp91phox and p47phox were reduced in isolated preglomerular arterioles of Ang-(1-7)-treated mice, compared with untreated mice, whereas eNOS expression was increased. CONCLUSION AND IMPLICATIONS: Chronic infusion of Ang-(1-7) improved renal endothelial function via Mas receptors, in an experimental model of human cardiovascular disease, by increasing levels of endogenous NO.
BACKGROUND AND PURPOSE: ApolipoproteinE-deficient [apoE (-/-)] mice, a model of humanatherosclerosis, develop endothelial dysfunction caused by decreased levels of nitric oxide (NO). The endogenous peptide, angiotensin-(1-7) [Ang-(1-7)], acting through its specific GPCR, the Mas receptor, has endothelium-dependent vasodilator properties. Here we have investigated if chronic treatment with Ang-(1-7) improved endothelial dysfunction in apoE (-/-) mice. EXPERIMENTAL APPROACH: ApoE (-/-) mice fed on a lipid-rich Western diet were divided into three groups and treated via osmotic minipumps with either saline, Ang-(1-7) (82 µg·kg(-1) ·h(-1) ) or the same dose of Ang-(1-7) together with D-Ala-Ang-(1-7) (125 µg·kg(-1) ·h(-1) ) for 6 weeks. Renal vascular function was assessed in isolated perfused kidneys. KEY RESULTS: Ang-(1-7)-treated apoE (-/-) mice showed improved renal endothelium-dependent vasorelaxation induced by carbachol and increased renal basal cGMP production, compared with untreated apoE (-/-) mice. Tempol, a reactive oxygen species (ROS) scavenger, improved endothelium-dependent vasorelaxation in kidneys of saline-treated apoE (-/-) mice whereas no effect was observed in Ang-(1-7)-treated mice. Chronic treatment with D-Ala-Ang-(1-7), a specific Mas receptor antagonist, abolished the beneficial effects of Ang-(1-7) on endothelium-dependent vasorelaxation. Renal endothelium-independent vasorelaxation showed no differences between treated and untreated mice. ROS production and expression levels of the NAD(P)H oxidase subunits gp91phox and p47phox were reduced in isolated preglomerular arterioles of Ang-(1-7)-treated mice, compared with untreated mice, whereas eNOS expression was increased. CONCLUSION AND IMPLICATIONS: Chronic infusion of Ang-(1-7) improved renal endothelial function via Mas receptors, in an experimental model of humancardiovascular disease, by increasing levels of endogenous NO.
Authors: María A Costa; María A Lopez Verrilli; Karina A Gomez; Pablo Nakagawa; Clara Peña; Cristina Arranz; Mariela M Gironacci Journal: Am J Physiol Heart Circ Physiol Date: 2010-07-30 Impact factor: 4.733
Authors: Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther Journal: Circulation Date: 2005-04-04 Impact factor: 29.690
Authors: L V d'Uscio; T A Baker; C B Mantilla; L Smith; D Weiler; G C Sieck; Z S Katusic Journal: Arterioscler Thromb Vasc Biol Date: 2001-06 Impact factor: 8.311
Authors: Annemarieke E Loot; Anton J M Roks; Robert H Henning; René A Tio; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst Journal: Circulation Date: 2002-04-02 Impact factor: 29.690
Authors: Andreas Patzak; Andreas Steege; En Yin Lai; Jan Ole Brinkmann; Eckehardt Kupsch; Nadine Spielmann; Adrian Gericke; Angela Skalweit; Johannes Stegbauer; Pontus B Persson; Erdmann Seeliger Journal: Am J Physiol Regul Integr Comp Physiol Date: 2007-10-24 Impact factor: 3.619
Authors: Sérgio Henrique S Santos; Luciana Rodrigues Fernandes; Erica Guilhen Mario; Adaliene Versiani M Ferreira; Laura Cristina J Pôrto; Jaqueline Isaura Alvarez-Leite; Leida Maria Botion; Michael Bader; Natalia Alenina; Robson Augusto S Santos Journal: Diabetes Date: 2007-11-19 Impact factor: 9.461
Authors: Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas Journal: Pharmacol Rev Date: 2015-10 Impact factor: 25.468
Authors: Anna Hammer; Guang Yang; Juliane Friedrich; Agnes Kovacs; De-Hyung Lee; Katharina Grave; Stefanie Jörg; Natalia Alenina; Janina Grosch; Jürgen Winkler; Ralf Gold; Michael Bader; Arndt Manzel; Lars C Rump; Dominik N Müller; Ralf A Linker; Johannes Stegbauer Journal: Proc Natl Acad Sci U S A Date: 2016-11-21 Impact factor: 11.205
Authors: Johannes Stegbauer; Sean E Thatcher; Guang Yang; Katharina Bottermann; Lars Christian Rump; Alan Daugherty; Lisa A Cassis Journal: J Vasc Surg Date: 2019-03-06 Impact factor: 4.268
Authors: Yang Zhang; Jian Liu; Jiang-Yun Luo; Xiao Yu Tian; Wai San Cheang; Jian Xu; Chi Wai Lau; Li Wang; Wing Tak Wong; Chi Ming Wong; Hui Yao Lan; Xiaoqiang Yao; Mohan K Raizada; Yu Huang Journal: Antioxid Redox Signal Date: 2015-05-14 Impact factor: 8.401